#ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Disea...

ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer’s Disease/Parkinson’s Disease 2025 International Conference

CAMBRIDGE, Massachusetts, March 24, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD),…

AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD 2025

AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025 AC Immune to host symposium highlighting the company’s industry-leading pipeline of active immunotherapies for precision prevention of neurodegenerative diseases Multiple presentations at the International Conference on Alzheimer’s and Parkinson’s Disease (AD/PD™ 2025) showcasing the diversity of the company’s precision medicine pipeline […]

Giovanna Carello Collar, a 27-year-old researcher and PhD student in Biochemistry at the Federal University of Rio Grande do Sul (UFRGS), caught the attention of the entire global scientific community when she won the One to Watch award from the Alzheimer’s Association International Conference (AAIC), which recognizes the next generation of leaders in the field of neuroscience. Held in Indiana, […]

New Biorepository at the DMCBH Aims To Accelerate Parkinson’s Research - Science in Vancouver

An innovative new initiative at the Djavad Mowafaghian Centre for Brain Health (DMCBH) is set to revolutionize research in Parkinson’s disease and related movement disorders. The establishment of the Bjorn Moller Research Repository, made possible by a generous donation from Bjorn and Rochelle Moller via the Pacific Parkinson’s Research Institute (PPRI), will allow biological samples to be shared across multiple studies, enhancing research effic…

#ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Disea...

ProMIS Neurosciences: Promising Advances in Antibody Therapeutics Amidst Competitive Revenue Challenges In a pivotal moment for the field of neurodegenerative disease research, ProMIS Neurosciences has recently showcased groundbreaking preclinical data regarding its antibody therapeutics and vaccines at the prestigious Alzheimer's Disease/Parkinson's Disease 2025 International Conference. The company's focus on selectively targeting toxic misfol…

California researchers have succeeded for the first time in synthesizing carnosic acid, which is also found in rosemary and sage, and it seems that this could be a major help in the fight against Alzheimer's disease.